135 related articles for article (PubMed ID: 36566320)
1. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC.
Devi-Marulkar P; Fastenackels S; Karapentiantz P; Goc J; Germain C; Kaplon H; Knockaert S; Olive D; Panouillot M; Validire P; Damotte D; Alifano M; Murris J; Katsahian S; Lawand M; Dieu-Nosjean MC
Commun Biol; 2022 Dec; 5(1):1416. PubMed ID: 36566320
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.
Fukuhara M; Muto S; Inomata S; Yamaguchi H; Mine H; Takagi H; Ozaki Y; Watanabe M; Inoue T; Yamaura T; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Shio Y; Suzuki H
Cancer Immunol Immunother; 2022 May; 71(5):1129-1137. PubMed ID: 34596720
[TBL] [Abstract][Full Text] [Related]
3. Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer.
Xiaoxu D; Min X; Chengcheng C
BMC Pulm Med; 2024 Mar; 24(1):155. PubMed ID: 38532454
[TBL] [Abstract][Full Text] [Related]
4. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer.
Di Modugno F; Di Carlo A; Spada S; Palermo B; D'Ambrosio L; D'Andrea D; Morello G; Belmonte B; Sperduti I; Balzano V; Gallo E; Melchionna R; Panetta M; Campo G; De Nicola F; Goeman F; Antoniani B; Carpano S; Frigè G; Warren S; Gallina F; Lambrechts D; Xiong J; Vincent BG; Wheeler N; Bortone DS; Cappuzzo F; Facciolo F; Tripodo C; Visca P; Nisticò P
EBioMedicine; 2024 Mar; 101():105003. PubMed ID: 38340557
[TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma.
Nakamura S; Ohuchida K; Hayashi M; Katayama N; Tsutsumi C; Yamada Y; Hisano K; Okuda S; Ohtsubo Y; Iwamoto C; Torata N; Mizuuchi Y; Shindo K; Nakata K; Moriyama T; Morisaki T; Oda Y; Nakamura M
Br J Cancer; 2023 Oct; 129(8):1314-1326. PubMed ID: 37604932
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Resident T Cells, Associated With Tertiary Lymphoid Structure Maturity, Improve Survival in Patients With Stage III Lung Adenocarcinoma.
Zhao H; Wang H; Zhao Y; Sun Q; Ren X
Front Immunol; 2022; 13():877689. PubMed ID: 35663939
[TBL] [Abstract][Full Text] [Related]
7. An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure.
Liu W; You W; Lan Z; Ren Y; Gao S; Li S; Chen WW; Huang C; Zeng Y; Xiao N; Wang Z; Xie H; Ma H; Chen Y; Wang G; Chen C; Li H
Cell Rep Med; 2024 Mar; 5(3):101448. PubMed ID: 38458196
[TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Kasikova L; Rakova J; Hensler M; Lanickova T; Tomankova J; Pasulka J; Drozenova J; Mojzisova K; Fialova A; Vosahlikova S; Laco J; Ryska A; Dundr P; Kocian R; Brtnicky T; Skapa P; Capkova L; Kovar M; Prochazka J; Praznovec I; Koblizek V; Taskova A; Tanaka H; Lischke R; Mendez FC; Vachtenheim J; Heinzelmann-Schwarz V; Jacob F; McNeish IA; Halaska MJ; Rob L; Cibula D; Orsulic S; Galluzzi L; Spisek R; Fucikova J
Nat Commun; 2024 Mar; 15(1):2528. PubMed ID: 38514660
[TBL] [Abstract][Full Text] [Related]
9. Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy.
Petroni G; Pillozzi S; Antonuzzo L
Cancer Res; 2024 Apr; 84(8):1199-1209. PubMed ID: 38381540
[TBL] [Abstract][Full Text] [Related]
10. Cellular and Vascular Components of Tertiary Lymphoid Structures.
Mueller CG; Nayar S; Gardner D; Barone F
Methods Mol Biol; 2018; 1845():17-30. PubMed ID: 30141005
[TBL] [Abstract][Full Text] [Related]
11. Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer.
Shahait M; Hakansson AK; Daniel RE; Hosny K; Davicioni E; Liu SY; Sandberg A; Lee DI; Lal P
Prostate; 2024 Jun; 84(8):709-716. PubMed ID: 38544351
[TBL] [Abstract][Full Text] [Related]
12. T follicular helper cells in cancer, tertiary lymphoid structures, and beyond.
Cui C; Craft J; Joshi NS
Semin Immunol; 2023 Sep; 69():101797. PubMed ID: 37343412
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity.
Khanal S; Wieland A; Gunderson AJ
Front Immunol; 2023; 14():1267654. PubMed ID: 37809103
[TBL] [Abstract][Full Text] [Related]
14. Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade.
Shu DH; Ho WJ; Kagohara LT; Girgis A; Shin SM; Danilova L; Lee JW; Sidiropoulos DN; Mitchell S; Munjal K; Howe K; Bendinelli KJ; Qi H; Mo G; Montagne J; Leatherman JM; Lopez-Vidal TY; Zhu Q; Huff AL; Yuan X; Hernandez A; Coyne EM; Zaidi N; Zabransky DJ; Engle LL; Ogurtsova A; Baretti M; Laheru D; Durham JN; Wang H; Anders R; Jaffee EM; Fertig EJ; Yarchoan M
bioRxiv; 2023 Oct; ():. PubMed ID: 37904980
[TBL] [Abstract][Full Text] [Related]
15. Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas.
Byers C; Gill M; Kurtansky NR; Alessi-Fox C; Harman M; Cordova M; Gonzalez S; Guitera P; Rotemberg V; Marghoob A; Chen CJ; Dy J; Kose K; Rajadhyaksha M; Sahu A
Front Med (Lausanne); 2022; 9():981074. PubMed ID: 36388913
[TBL] [Abstract][Full Text] [Related]
16. Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.
Braud VM; Biton J; Becht E; Knockaert S; Mansuet-Lupo A; Cosson E; Damotte D; Alifano M; Validire P; Anjuère F; Cremer I; Girard N; Gossot D; Seguin-Givelet A; Dieu-Nosjean MC; Germain C
Oncoimmunology; 2018; 7(5):e1423184. PubMed ID: 29721382
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio are Prognostic Factors in Pulmonary Metastases from Uterine Leiomyosarcoma.
Matsuda N; Yamamoto H; Habu T; Takahashi K; Toyooka S
Ann Surg Oncol; 2023 Dec; 30(13):8757-8758. PubMed ID: 37648886
[No Abstract] [Full Text] [Related]
18. Tertiary lymphoid structures and B cells: An intratumoral immunity cycle.
Fridman WH; Meylan M; Pupier G; Calvez A; Hernandez I; Sautès-Fridman C
Immunity; 2023 Oct; 56(10):2254-2269. PubMed ID: 37699391
[TBL] [Abstract][Full Text] [Related]
19. The mast cell-T lymphocyte axis impacts cancer: Friend or foe?
Kannen V; Grant DM; Matthews J
Cancer Lett; 2024 Apr; 588():216805. PubMed ID: 38462035
[TBL] [Abstract][Full Text] [Related]
20. Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients.
Yin YX; Ling YH; Wei XL; He CY; Wang BZ; Hu CF; Lin WP; Nie RC; Chen JW; Lin JL; Zhou J; Xie JJ; Yun JP; Xie D; Xue LY; Cai MY
Front Immunol; 2022; 13():973085. PubMed ID: 36591236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
